Immunopathogenesis and prevention of uveitis with the Behçet's disease-specific peptide linked to cholera toxin B.
Lehner
T
T
Guy's, King's and St Thomas' Hospital Medical School, Kings College, London, England.
Stanford
M R
MR
Phipps
P A
PA
Sun
J B
JB
Xiao
B G
BG
Holmgren
J
J
Shinnick
T
T
Hasan
A
A
Mizushima
Y
Y
D001426:Bacterial Proteins; D001528:Behcet Syndrome / Q000209:etiology* / Q000276:immunology* / Q000517:prevention & control; D018834:Chaperonin 60; D018833:Chaperonins / Q000276:immunology*; D002772:Cholera Toxin / Q000276:immunology*; D003429:Cross Reactions; D006561:Herpes Simplex / Q000276:immunology; D018259:Herpesvirus 1, Human; D006801:Humans; D007114:Immunization; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000150:complications*; D013298:Streptococcus sanguis / Q000276:immunology; D014605:Uveitis / Q000209:etiology / Q000517:prevention & control
D001426:Bacterial Proteins; D018834:Chaperonin 60; D011993:Recombinant Fusion Proteins; C074119:heat-shock protein 65, Mycobacterium; D002772:Cholera Toxin; D018833:Chaperonins